Parabilis Medicines, Inc. (PBLS)

39.83 -0.28 (-0.70%) USD  |  NASDAQ  |  Sep 03, 13:40
More

Parabilis Medicines Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for PBLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Kailera Therapeutics, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. Upgrade